Post-Authorisation Safety Study of Paediatric Patients Initiating Selumetinib: A Multiple-Country Prospective Cohort Study

03/03/2022
20/05/2026
EU PAS number:
EUPAS45972
Study
Ongoing
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

D1346R00004_Protocol V 2.0_05Nov2021_Redacted

English (359.51 KB - PDF) View document
Study results
Study report
Abstract of study report

D1346R00004-PASS Annual Progress Report 1_Redacted.pdf

English (3.04 MB - PDF) View document

D1346R00004-PASS Annual Progress Report 2_Redacted.pdf

English (4.52 MB - PDF) View document
Other information